Sensei Biotherapeutics, Inc. (SNSE) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts SNSE Hot Sheet
Join SI Premium – FREE
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q3 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Goldman Sachs Upgrades Drax Group Plc. (DRX:LN) (DRXGY) to Buy
- UBS Downgrades Zhaojin Mining Industry Co Ltd (1818:HK) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
